Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.

2532 Background: Breast cancers in men (BCM) account for <1% of all breast cancers. Dihydrotestosterone (DHT) inhibits proliferation of normal and neoplastic mammary tissue and constrains the effec...